Fore Biotherapeutics: Funding, Investors & Team (Oct 2026)
Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics. The company is creating a pipeline of precision oncology treatments aimed at patients with unaddressed mutations across well-established oncology targets.
Fore Biotherapeutics has raised $142M across 2 funding rounds on record, the most recent a Series D of $67.4M announced in Jul 2026.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Fore Biotherapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2026.
Fore Biotherapeutics Funding Rounds
Fore Biotherapeutics raised $75.0M in a Series D announced in Aug 2023.
2.9 years later, a Series D of $67.4M was announced in Jul 2026.
Fore Biotherapeutics Investors
20 investors are recorded in total; the 5 named above are those the record identifies.
Fore Biotherapeutics Founders and Leadership Team
Contact details for the Fore Biotherapeutics team: 1 of 3 have an email address on file.
Start 14-day free trial →Fore Biotherapeutics Funding Compared to Other Biotechnology Startups
Fore Biotherapeutics' latest round of $67.4M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Fore Biotherapeutics in Biotechnology and Philadelphia
Companies Similar to Fore Biotherapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Fore Biotherapeutics Funding FAQs
What does Fore Biotherapeutics do?
Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics. The company is creating a pipeline of precision oncology treatments aimed at patients with unaddressed mutations across well-established oncology targets.
How much funding has Fore Biotherapeutics raised?
Fore Biotherapeutics has raised $142M across 2 rounds on record. The most recent is a Series D of $67.4M announced in Jul 2026.
When did Fore Biotherapeutics last raise funding?
Fore Biotherapeutics' most recent funding round on record is a Series D of $67.4M, announced in Jul 2026.
Who has invested in Fore Biotherapeutics?
Investors on record for Fore Biotherapeutics include Wellington Management, Cormorant Asset Management, OrbiMed, SR One, Medicxi. FundedIQ records 20 investors in total.
Who founded Fore Biotherapeutics?
FundedIQ lists Michael (Founder & CEO) at Fore Biotherapeutics.
Who is the CEO of Fore Biotherapeutics?
William is listed as Chief Executive Officer at Fore Biotherapeutics.
Where is Fore Biotherapeutics headquartered?
Fore Biotherapeutics is based in Philadelphia, Pennsylvania, United States.
How many employees does Fore Biotherapeutics have?
Fore Biotherapeutics is in the 11-50 employee band.
When was Fore Biotherapeutics founded?
Fore Biotherapeutics was founded in 2011.
How does Fore Biotherapeutics' funding compare to other Biotechnology startups?
Fore Biotherapeutics' latest round of $67.4M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Fore Biotherapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Fore Biotherapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.